INTRODUCTION
The human genome has 3 billion base pairs with 3-5% as coding exons that account for about 100,000-140,000 genes. The Human Genome Project is scheduled to complete the sequencing of the entire genome in the next few years. At the present time, the Expressed Sequence Tags (ESTs) in the GenBank represent Ͼ60% of the human genes. Mammalian genes exist in families as reflected by the presence of multiple paralogs. With recent advances in bioinformatic tools, the massive resources in the GenBank are easily accessible to investigators through the Internet and allow opportunities for discoveries that could impact all fields of biomedicine. Using Internet-based tools to search the massive genome databases, it is possible to identify new endocrine genes based on evolutionary conservation, domain homology, and tissue expression patterns. Examples for the discovery of paralogous genes include: LGRs (leucine-rich repeat containing, G protein-coupled receptors) that are evolutionarily conserved as compared with gonadotropin and TSH receptors, and RIFs (relaxin-insulin-like factors) that show domain conservation with known growth factors. Using the GenBank searches, polymorphism of previously characterized genes can also be identified. The rapid pace of genomic revolution allows the discovery of new genes in the endocrine systems, identification of new drug targets, analysis of genetic susceptibility of individuals to endocrine diseases, and customized drug therapy based on gene polymorphism. It is anticipated that the future integration of gene sequence-based approaches with transcript expression profiles and protein functions will lead to a more complete understanding of the circuitry controlling the endocrine pathways.
GENOMIC REVOLUTION
The recent genomic revolution officially started in 1992 with the launching of the Human Genome Project (1) . It is anticipated that, within the next few years, sequencing of the entire 3 billion (3 ϫ 10 9 ) base pairs of the human genome will be completed. At the present time, the complete genomic sequences of more than 2 dozen organisms including yeast Saccharomyces cerevisiae and nematode Caenorhabditis elegans are already available. This progress has been compared with the completion of the Periodic Table of the Elements at the end of the 19th century (2) and became possible through the largely automated sequencing of libraries of genomic DNA and expressed sequence tags (ESTs) that represent fragments of sequenced cDNAs from diverse tissues. At the beginning of April 2000, the GenBank contained more than 2.4 billion bases of human genome sequences and the complete sequencing of the entire human genome has just been announced (for an update of deposited sequences see http://www.ornl.gov/hgmis/project/ progress.html). In addition to ESTs, these sequences are represented by single-pass genome survey sequences (GSS) encompassing the ends of large genomic fragments, unfinished and unordered highthroughput genomic sequences (HTGS), and finished nonredundant (NR) sequences. Among the various GenBank sequences, the EST database is particularly useful for identifying novel genes (3, 4) . These short sequences represent transcribed genes and contain continuous protein coding regions. The 1.8 million human ESTs presently in the GenBank have been clustered into approximately 92,224 unique transcripts (Unigene Build 107, Jan. 27, 2000) based on their overlapping sequences, therefore accounting for more than 60% of human genes (http://www.ncbi.nlm.nih. gov/UniGene/Hs.stats.shtml). It is clear that the EST sampling approach has identified a majority of transcripts encoded by our genome. Indeed, more than 90% of known or nonredundant genes of human or mouse origin are represented by at least one EST (1). Thus, the EST and other gene sequence databases have become indispensable for gene discovery.
TRADITIONAL VS. GENBANK APPROACHES FOR THE DISCOVERY OF ENDOCRINE GENES
Using function-and phenotype-driven approaches, traditional studies of endocrine signaling molecules are based upon purification of hormones and receptors in specific glands and targets, respectively. Intracellular signaling molecules were also isolated through protein purification and, more recently, through protein-protein interaction assays such as coprecipitation of proteins (5) ( Table 1) . After the advent of recombinant DNA technology, the discovery of endocrine signaling molecules has been expanded to include searches based on 1) sequence similarity to known genes using low-stringency hybridization, 2) PCR with degenerate primers, and 3) differential cloning (subtraction and differential display) (6, 7) . The proteinprotein interaction searches were also expanded to include expression cloning based on ligand or antibody binding (8) (9) (10) and yeast two-hybrid interaction assay (11) (12) (13) . In addition, some endocrine genes (e.g. MEN1) were isolated based on genetic analysis in diseased individuals and positional cloning after chromosome walking (14). Although the recombinant DNA approach has allowed the successful discovery of new hormones, receptors, and intracellular mediators, the genomic revolution exemplified by the rapid GenBank expansion has prompted another paradigm shift in the identification of novel endocrine factors with the ultimate goal of finding all endocrine regulatory genes. With major advances in bioinformatic tools available on the Internet (Table 2) , the massive resources in the GenBank are easily accessible to investigators and allow opportunities for major discoveries that could impact endocrinology as well as all fields of biomedicine. The new approach takes advantage of the unprecedented power of modern computing tools and minimizes the use of the time-consuming laboratory bench-based wet science. Initial discoveries of novel genes can be performed in minutes, followed by further verification and characterization using the benchtop approaches. In addition, the tedious stringency control procedures in the traditional cloning methods based on sequence matching (e.g. degenerate PCR and low-stringency hybridization) are now replaced by changing the expectation or threshold values during computational searches. The scale of economy for this approach is obvious: computational searches take only minutes and can encompass sequences derived from diverse organisms and tissue or cell origins. A comparison of the computational search vs. PCR amplification for novel gene discovery is shown in Table 3 .
GENBANK SEARCHES FOR NOVEL PARALOGOUS ENDOCRINE GENES
Although previously predicted, based on traditional approaches, the concept that mammalian genes are present in families is strengthened by the recent comparison of genome sequences in diverse organisms (15). In addition to the identification of orthologous human genes with conserved structure and function in lower organisms (16, 17), multiple paralogous genes evolve from the same ancestral gene during the evolution of simple organisms into complex ones. Genes evolved through domain rearrangement and gene fusion. New genes can change their molecular specificity but remain in the similar regulatory circuitry or may be recruited to serve completely new functions in a novel regulatory linkage. In addition, new domains can evolve through domain combination and shuffling. tion of genes that are related but with limited primary sequence homology, a variety of sequence-based computation tools and databases such as eMOTIF and BLOCKS (Table 2 ) have been developed to further optimize the discovery of sequence relatedness among genes and for the development of phylogenetic and evolutionary models. Moreover, a search of gene relatedness based on the structure of translated products has also been explored (SCOP) to reveal potential functional relationships. To facilitate analysis of intronexon arrangements of the unorganized HTGS and GSS genomic sequences, gene recognition algorithms have also been developed (Genie, GRAIL, etc).
Among the large number of ESTs and genomic entries in the GenBank, sequences not identical to known ones but that share similarity either in the entire structure or in selected domains are the most obvious candidates for further study. In general, the relatedness is obvious for an unknown gene that shares Ͼ40% identify with a known gene in its primary sequences. While proteins with this level of identity likely represent paralogs and could have similar functions, most novel sequences require further validation of their putative physiological roles.
GENES WITH CLOSE EVOLUTIONARY ORIGIN
Taking advantage of the evolutionary conservation of the primary sequence of genes that diverge during evolution, comparison of novel genes with known family proteins can lead to identification of paralogous genes. The classical example of a gene search using this approach is the identification of multiple orphan receptors more than a decade ago, which was based mainly on low-stringency hybridization cloning. The term orphan receptor was coined to describe gene products that belong to the nuclear receptor superfamily on the basis of sequence identity but without known ligands. Orphan receptors have been identified in most metazoans and include about 40 human genes (26, 27). The cloning of the orphan receptors ushered in the exciting new concept of reverse endocrinology. The reversed endocrine discovery process led to the identification of vitamin A metabolite 9-cis retinoic acid as a ligand for the retinoid X receptor (RXR) family of orphan receptors (28, 29). In addition, various hormones belonging to the transforming growth factor-␤ (TGF-␤) superfamily, including different growth differentiation factors (GDFs) and bone morphogenic proteins (BMPs), have been identified based on degenerate PCR amplification and low-stringency screening (30, 31). Likewise, a variety of tyrosine kinase receptors (32-34), serine/threonine kinase receptors (type I and II receptor for TGF-␤ superfamily proteins) (8, (35) (36) (37) , and chemokines (38) were isolated using the same approach. More recently, up to 80 orphan G protein-coupled receptors have been identified largely through the cloning of genes sharing the unique seventransmembrane domains by using PCR with degenerate primers (39, 40).
Using the computation approach, additional G protein-coupled receptors have been identified in the GenBank based on sequence conservation in the transmembrane region (40, 41). Recently, we have identified four novel leucine-rich repeat-containing, G protein-coupled receptors (LGR) sharing significant homology with known glycoprotein receptors from vertebrates using the sequences of primitive homologs isolated from Drosophila and snail Lymnanei stagnalis (42, 43) as queries for the GenBank search. Using the same evolutionary conservation approach, a number of genes homologous to mammalian glycoprotein hormone receptors were identified from nematode (44) and Drosophila (S. Y. Hsu, S. Nishi, and A. J. W. Hsueh, unpublished data). Of interest, the nematode LGR protein expressed in mammalian cells showed constitutive activity, resembling the point mutations found in the LH receptor gene in patients with familial male-limited precocious puberty (45, 46) and in the TSH receptor gene in patients with nonautoimmune hyperthyroidism (47). The finding of these novel leucine-rich repeat-containing, G protein-coupled receptors in diverse phylogenies has allowed 1) the determination of the consensus sequences and constituent motifs in these receptors, 2) the identification of additional LGRs, 3) the construction of a gene family tree and evolutionary models for these receptors, and 4) the improvement of the modeling of LGR protein structures (48). Although these novel receptors shared identical domain arrangement with glycoprotein hormone receptors, diversification in their primary sequences has predicted their binding to novel ligands, thus providing opportunities for reverse endocrinology. Similar bioinformatic searches have resulted in the identification of multiple cytokines (http:// cytokine.medic.kumamoto-u.ac.jp/CFC/CK/Chemo- 
GENES WITH LIMITED SIMILARITY IN SELECTIVE MOTIFS
While paralogous genes sharing an overall similarity can be identified with ease, discovery of related genes with limited similarity in selective motifs require an in-depth understanding of the structure-function of the common motif. Traditionally, low-stringency hybridization and degenerate PCR based on shared sequence motifs are the main approaches for identifying this group of paralogous genes. However, this approach becomes inefficient and impractical when the consensus motif is short and the similarity among homologous genes is low. In contrast, computation approaches allow the scanning of similarity along the entire length of candidate genes, based on conservation in stretches of primary sequences or in the presumptive secondary structure ( Table 3 ). The confidence on sequence matches among remote homologs could gradually be optimized by focusing on comparison in regions corresponding to active sites or functional motifs that are most likely to be shared among divergent members. Thus, the computational approach is especially fruitful when the homology among paralogous genes is low but the functional motif(s) of known family members are well characterized. For example, proteins in the insulin superfamily were grouped based on their conserved tertiary structure of mature proteins. These proteins include insulin, insulin-like growth factors I and II (IGF-I, IGF-II), relaxin, Leydig cell relaxin, and EPIL (early placenta insulin-like factor) in vertebrates as well as molluscan insulin-like peptides and bombyxins in invertebrates (56) . Six cysteine residues important for interchain disulfide bond formation are completely conserved in these otherwise remotely related polypeptides. Using the conserved domain sequences as query, we have isolated two novel relaxin/insulin-like factors (RIFs) sharing close homology with relaxin in the putative mature portion of these polypeptides (56) . Although RIFs share low overall sequence similarity (Ͻ30%) with proteins in the insulin/relaxin superfamily, the disulfide bond-forming cysteine residues are completely conserved. Indeed, it is difficult to identify these molecules using traditional sequence-matching methods.
Among genes involved in apoptosis, the death effector domain represents a stretch of about 80 amino acids that is shared by adapters, regulators, and executors of the tumor necrosis factor-␣ (TNF-␣)/Fas pathway. Based on the conservation of this domain, GenBank searches have also allowed us to isolate an intracellular apoptosis mediator DEFT (death effector in testis) that is abundantly expressed in the testis (57) .
GENBANK SEARCHES FOR POLYMORPHISMS OF KNOWN GENES
In addition to the discovery of novel genes, the computational approach also allows the unique opportunity to identify polymorphisms of known genes encoding proteins with different functional characteristics. Single nucleotide polymorphism (SNP) represents single nucleotide changes in the same gene among individuals (58) . These minor alterations occur with varying frequencies in different ethnic populations and are the central focus of pharmacogenomic studies. It has been estimated that there are 300,000 potential SNPs in the human genome (59, 60) . Although SNPs were traditionally characterized by single-strand conformational polymorphism (SSCP) analysis, the accumulation of multiple sequences of a given gene in the GenBank allows future polymorphism discovery when sufficient sequences of the same gene are aligned. The importance of endocrine gene polymorphism is illustrated by polymorphisms of cytochrome P450 genes associated with abolished or enhanced drug metabolism in patients (61, 62) and a chemokine receptor CCR-5 polymorphism associated with human immunodeficiency virus (HIV) resistance (63) . Other examples include polymorphisms in ␤-adrenergic receptors and sensitivity to ␤-agonists in asthmatics (64), angiotensin-converting enzymes (ACE) and sensitivity to ACE inhibitors (65, 66) , angiotensin II type 1 receptors and vascular reactivity to phenylephrine (67) , and hydroxtryptamine receptors and responsiveness to neuroleptics such as clozapine (68) . The identification of these polymorphisms not only contributed to the study of pharmacology and epidemiology but also allowed the elucidation of functional mechanisms of some of the receptors. For hormone ligands, the human LH␤ gene has two linked SNPs (Trp8Arg and Ile15Thr) that are known to encode proteins exhibiting altered immunoassay properties (69) and show distinct carrier frequency among different racial groups. Furthermore, polymorphisms in the promoter of the chemokine RANTES gene are associated with changes in the secretion of this ligand for CCR-5, thus altering the chance of HIV infection (70) . In the future, analysis of gene polymorphism using the informatic approach could allow one to identify the genetic susceptibility of individuals to some endocrine diseases and to customize hormonal treatment protocols for individual patients.
LIMITATIONS IN THE MINING OF GENE SEQUENCE DATABASES
Although the existing computation algorithm for gene sequence analysis is powerful, there are limitations. Sequences obtained through the high-throughput DNA analysis are generated by automated single-pass analysis of DNA. As a result, sequences may contain mistakes, deletions, or insertions. In addition, the annotation of many sequence entries may have mistakes. Thus, despite the unprecedented opportunity to access the gigantic databases, conflicting information derived from such archives requires careful scrutiny to weed out false positives including sequencing errors, annotation mistakes, pseudogenes, multiple copies of recently duplicated and highly homologous genes (e.g. hCG-␤), and a combination of these common artifacts. These pitfalls are particularly imminent when one is studying families of proteins with close sequence homology or is focusing on detailed features (such as polymorphism) of sequences. The relatedness of diverse genes could theoretically be decided based on pairwise sequence comparison and motif search programs. Although sequences that share less than15-20% identity could have sequencefunction relatedness, most genes with this level of identity are likely to perform distinct functions. In addition, the majorities of sequenced genes in the GenBank either have limited sequence similarity to known genes or have no sequence references. It is becoming clear that sequence-independent approaches are required to augment the powerful sequence-based gene discovery.
INTEGRATION OF GENOMIC INFORMATION AND KNOWN LITERATURE ON GENE FUNCTION
With the anticipated sequencing of the human genome, future gene discovery no longer involves the physical cloning of new genes but will include consolidation and integration of existing sequences and the identification of gene functions. To gain insight into the potential roles of individual genes in our genome, several new approaches have been developed to facilitate the organization and dissemination of data from GenBank and the existing literature, as well as to streamline the data extraction process for identifying gene functions.
SEQUENCE-BASED CLUSTERING OF INDIVIDUAL DNA SEQUENCES
Multiple sequences derived from the same gene were submitted to the GenBank by different investigators, and a given gene may have different entries (e.g. contiguous and noncontiguous genomic sequences, mRNA sequences with alternative splicing, and ESTs). Because it is not yet routine to identify all genomic regions that are transcribed, the integration of EST sequences and genomic sequences is necessary to identify all coding regions. To consolidate all sequences derived from the same gene, a number of databases such as UniGene, STACK, and TIGR have been set up (Table 2 ) (71). The UniGene collection has grouped more than 1.8 million ESTs of human origin into clusters of unique sequences, each representing the transcription product of a distinct human gene. This collection provides nonredundant mapping candidates for generating gene expression profiles in diverse tissues. Moreover, the organization of gene sequences in this format has allowed investigators to perform virtual library subtraction experiments in a tissue-or cell-specific manner across the whole body through simple query (72) .
Due to the recent rapid expansion of HTG sequences, it is anticipated that the majority of DNA sequences in the GenBank will be in the form of unfinished genomic sequences in the near future. Because these sequences are derived from single or few reads of DNA clones, they are unordered, unoriented, and contain gaps and errors. To analyze this type of sequence, sophisticated algorithms that integrate the analysis of different gene features have been developed. For example, the Genotator and NIX packages provide workbenches for automated sequence annotation and annotation browsing ( Table 2 ). The programs integrate multiple gene-finding tools, homology searches, and algorithms for identifying promoters, splice sites, and open reading frames. The results are presented using a graphic browser to facilitate gene analysis. The tradeoff of such convenience is the lack of options to alter the stringency of analysis. However, even the best tools rarely perform at more than 75% accuracy. Indeed, recent studies indicated that, in addition to the 6,200 predicted genes, 300 novel genes can be identified in yeast using genome-wide transposon disruption; these genes were not recognized based on the most sophisticated algorithm tools (73) .
INTEGRATION OF GENE SEQUENCES WITH TEXT-BASED LITERATURE ON GENE FUNCTION
With the explosion of gene sequences, one of the major challenges facing genomic researchers today is the integration of sequence data with the vast and growing body of literature based on functional analyses of genes. The implementation of a user-friendly interface for easy query of diverse databases is necessary for both novice and experienced investigators who seek to sort out the expanding knowledge base of gene sequence and functions. The Online Mendelian Inheritance in Men (OMIM) database (http://www.ncbi.nlm.nih.gov/Omim/) provides a searchable web-based dynamic database of hu-man genes and genetic disorders. Each gene entry contains textual information and hypertext links to the GenBank database and PubMed, allowing quick reference checks for most known genes. In addition, multiple online databases for specific gene groups or tissues have been developed. For example, several databases (GPCRDB, GCRDb, GRAP, ORDB, CORD, and Swiss Model 7TM Interface, accessible through the portal site http://www.opioid.umn.edu/ links.html) organize information on the G proteincoupled receptors into searchable databases, allowing users to browse and analyze the molecular and physiological data of this largest protein family in eukaryotic organisms (74) . Likewise, the Nuclear Receptor Resource (NRR) Project (http://nrr.georgetown.edu/NRR/NRR.html) is a collection of individual databases on members of the steroid and thyroid hormone receptor superfamily. In addition, we have developed a database on ovarian genes. The Ovarian Kaleidoscope Database (http://ovary.stanford.edu/) provides information regarding the biological function, expression pattern, and regulation of genes expressed in the ovary. It also serves as a gateway to other online information resources offering data about nucleotide and amino acid sequences, chromosomal localization, human and murine mutation phenotypes, and biomedical publications relevant to ovarian research. For all these databases, gene sequence and functional information are interlinked. Continuing development of databases and portal sites focusing on specific biomedical areas would allow easy access to updated and organized discipline-specific information and perhaps make the analysis of gene sequences part of routine literature searches.
FUTURE IDENTIFICATION OF GENE FUNCTIONS
Among the human genes, currently less than 8% are considered to be known genes with different levels of functional characterization (75) . The inadequacy of a sequence alignment-based approach to determine the functions of most sequenced genes has prompted the development of a variety of experimental procedures to utilize the genomic information more efficiently and to provide alternative ways for the annotation of novel genes. With the anticipated availability of entire human genome sequences, the traditional positional cloning approach will be replaced by virtual chromosomal walking of the ordered genome sequences. Furthermore, the present single gene knockout approach for gene function identification will be replaced by random genomewide gene deletion (http://www.lexgen.com/k) or targeted gene trapping (76, 77) . The secretory trap method based on capturing the N-terminal signal peptide sequence of an endogenous gene to generate an active reporter fusion protein has allowed the generation of mice with a deletion of genes encoding membrane and secreted proteins (77) (78) (79) (80) . Among the several hundred mutant strains generated (http://socrates.berkeley.edu/ ϳskarnes/resource.html), many are defective in ligand or receptor genes important for endocrine research. Integration of this collection of mutant mice with the expanding GenBank database will continue to allow characterization of new hormones and receptors.
DNA ARRAY FOR EXPRESSION PROFILING AND POLYMORPHISM SEARCH
The development of high-density DNA microarrays has allowed the analysis of the expression of thousands of genes simultaneously (81) . By combining this technology with the vast EST collection, investigators now can quickly group genes showing similar expression profiles. The DNA array method has allowed the genotyping of physiological processes and the understanding of regulatory mechanisms in a global manner without detailed functional analysis of individual genes. For example, one can detect changes of gene expression based on hybridization to cDNAs from different physiological states (before and after endocrine ablation), diseased progression stages (normal vs. diseased) and treatment periods (pre-vs. post-) (82) . In addition, the sequencing-by-hybridization approach based on array analysis of overlapping oligomers corresponding to the entire sequence of a known gene allows detection of mutations or polymorphism of individual genes (83) .
FACILITATION OF PROTEIN DISCOVERY USING GENBANK SEARCH
The classical protein purification approach for identifying endocrine proteins will be accelerated by matching EST databases with peptide sequences derived from two-dimensional gel electrophoresis analysis followed by peptide mass fingerprinting with MALDI-TOF (matrix-assisted laser-desorptionionization-time-of-flight) mass spectrometry. Modern mass spectrometers can provide sufficient information to allow unique recognition of protein fragments, as well as detection of secondary modifications such as phosphorylation and glycosylation. Alternatively, it may be possible to devise chip detectors for ligands, receptors, and intracellular signaling mediators. In addition, integration of a genome database with protein coprecipitation and global yeast two-hybrid interaction approaches should allow the assembly of comprehensive interaction maps of genomes (84, 85) and the routine identification of downstream components of cell surface receptors in mammalian cells (86) .
THREE-DIMENSIONAL STRUCTURE COMPARISON
Because the folding of a protein is the result of a collective interaction among its constituent amino acid residues, comparison of proteins based on their secondary or tertiary structures represents an alternative approach for predicting gene functions. Important information can be extracted regarding the fold of a protein embedded in the length and arrangement of the predicted helices, strands, and coils along the polypeptide chain. As the number of polypeptides with determined secondary or tertiary structures is increased, this approach will become more useful to identify the function of uncharacterized genes (87, 88) .
INTEGRATION OF EXPRESSION, PATHWAY, AND PHYLOGENETIC PROFILING
By phylogenetic comparison of sequence data with experimental data on correlated mRNA expression patterns, protein-protein interactions, or protein functions in a given species, the researcher is able to infer protein functions through properties other than sequence similarity (89) (90) (91) (92) . Studies on genomes of lower organisms have demonstrated that a great number of genes are created through multiple fusion events during evolution, and genes that have fused are likely to interact with each other in the same signaling pathway (93) (94) (95) . In addition, previously unidentified genes associated with prostate cancer, steroid synthesis, insulin synthesis, and neurotransmitter processing can be discovered by using a guilt-by-association approach based on coordinated expression of genes in different cDNA libraries (96) .
CONCLUSIONS
Historically, most endocrine factors have been defined based on phenotypic changes. As the genome projects progress, the massive archives in the GenBank represent a golden opportunity to discover new hormones, receptors, and signaling molecules. Through sequence analysis, paralogous novel endocrine genes can be isolated, and furthermore, polymorphisms of known genes can be identified. Although gene sequence-based approaches cannot completely replace the traditional biochemical and physiological characterization of endocrine mediators, they have greatly facilitated the identification and analysis of new genes. The ongoing shift in the investigation from one gene at a time to a global approach necessitates new methods to integrate the explosion of knowledge on gene sequences, transcript expression profiles, and protein functions and interactions. Although all human genes will be known in a few years, major challenges await endocrinologists to elucidate the physiological roles of all hormones, receptors, and signaling mediators. The greatest challenge will be to decipher the logical circuitry controlling all endocrine pathways. 
